Skip to Main Content

Skip Nav Destination

Letter| January 9, 2025

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study

Francesco Pegoraro,

Francesco Pegoraro

University of Florence, Firenze, Italy

https://orcid.org/0000-0002-4954-5744

Search for other works by this author on:

PubMed

Google Scholar

Francesco Catamerò,

Francesco Catamerò

Department of Health Sciences, University of Florence, Florence, Italy, Florence, Italy

https://orcid.org/0009-0001-5633-9025

Search for other works by this author on:

PubMed

Google Scholar

Francesco Peyronel,

Francesco Peyronel

University of Florence, Florence, Italy

https://orcid.org/0000-0001-8470-1952

Search for other works by this author on:

PubMed

Google Scholar

Federica Allegretta,

Federica Allegretta

University of Florence, Florence, Italy

Search for other works by this author on:

PubMed

Google Scholar

Giulia Palazzini,

Giulia Palazzini

University of Florence, Florence, Italy

Search for other works by this author on:

PubMed

Google Scholar

Eli L Diamond,

Eli L Diamond

Memorial Sloan Kettering Cancer Center, New York, New York, United States

https://orcid.org/0000-0001-5456-5961

Search for other works by this author on:

PubMed

Google Scholar

Augusto Vaglio

Augusto Vaglio

University of Florence, Italy

* Corresponding Author; email: augusto.vaglio@unifi.it

Search for other works by this author on:

PubMed

Google Scholar

Blood Adv bloodadvances.2024015399.

https://doi.org/10.1182/bloodadvances.2024015399

This content is only available as a PDF.

Copyright © 2025 American Society of Hematology

2025

Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Supplemental data